Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 1

Conditions

Hemophilia A 4Anemia, Sickle Cell 4Thrombocytopenia 2Anemia 2Venous Thromboembolism 1Vaso-Occlusive Crises 1Renal Anemia 1Purpura, Thrombocytopenic, Idiopathic 1Purpura, Thrombocytopenic 1Priapism 1Ovarian Neoplasms 1Myelodysplastic Syndromes 1Leukemia, Lymphocytic, Chronic, B-Cell 1Fanconi Anemia, Complementation Group D1 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has announcements × Priapism × Classical hematology × Clear all
NCT01895361 2020-01-31

SUSTAIN

Reprixys Pharmaceutical Corporation

Phase 2 Completed
198 enrolled 18 charts 1 FDA
Classical hematology

Anemia, Sickle Cell, Priapism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡